Webb Carol 4
4 · CITIUS ONCOLOGY, INC. · Filed Aug 14, 2024
Insider Transaction Report
Form 4
Webb Carol
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-08-12+150,000→ 150,000 totalExercise: $2.15Exp: 2033-07-05→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option, originally issued by Citius Oncology Sub, Inc., is 100% vested. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.